Rueegg, CurzioPeters, Solange2010-11-302010-11-302010-11-30200910.1093/jnci/djp208https://infoscience.epfl.ch/handle/20.500.14299/59944WOS:000268812900001Phase-Ii TrialMaintenance TherapyTumor AngiogenesisMultiple-MyelomaDouble-BlindChemotherapyGrowthThalidomide in Small Cell Lung Cancer: Wrong Drug or Wrong Disease?text::journal::journal article::research article